Cathelicidin Antimicrobial Peptide
CAMPproteinCAMP mediates antiplatelet signaling and immune regulation during acute myocardial injury.
Pathway placement
Cascade stepPlatelet adhesion & activation
Confidencemedium
RationaleAntiplatelet signaling effector and immune regulator in AMI pathogenesis.
Also acts inVascular inflammation
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000164047
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(4)
- Identification of key proteins and pathways in myocardial infarction using machine learning approaches.Scientific reports · 2025 · PMID 40467768 · doi
- Weighted gene co-expression network analysis identifies specific modules and hub genes related to coronary artery disease.Scientific reports · 2021 · PMID 33758323 · doi
- rLj-RGD3, a novel recombinant toxin protein from Lampetra japonica, prevents coronary thrombosis-induced acute myocardial infarction by inhibiting platelet functions in rats.Biochemical and biophysical research communications · 2018 · PMID 29407168 · doi
- Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice.British journal of pharmacology · 2016 · PMID 27435156 · doi